Beta: Sign in
Shares outstandingAs of 2026-08-05 · filed common shares: 103.38M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 12.24%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 0.70%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 38.80%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 31.10%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginFY Mar 25: 48.70%
Operating marginFY Mar 25: -585.84%
Net margin: —
EBITDA marginFY Mar 25: -537.21%
Return on equityNet income (FY Mar 25) ÷ average shareholders equity: -104.34%
Return on assetsNet income (FY Mar 25) ÷ average total assets: -76.38%

Growth

Revenue growth (annual YoY): -5.50%
Revenue growth (latest qtr YoY): -19.21%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Mar 25

-0.09

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $331.00K
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $149.00K
Debt / equityas of Jun 26: 2.43%
Current ratioas of Jun 26: 0.39
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 0.13
Operating cash flowTTM to Sep 25: -$5.54M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Sep 25: -$5.62M
TTM revenue / diluted shareDiluted, FY Mar 25: 0.02

IGC stock Statistics — IGC Pharma, Inc. filings, insiders & smart money · Instaport